Gifu

October 21, 2023

Gifu # Crispr ageinst resistance # Our Gifu team is focused on addressing future antibiotic-resistant bacterial infections using the Cas system. We aim to eliminate the genes contributing to this resistance, thus neutralizing the bacteria’s defense and halting their spread. The CRISPR-MultiTargeter tool aids in designing gRNAs targeting common parts of these bacteria, ensuring effectiveness despite mutations. We aspire to integrate this system into phages for efficient phage therapy, offering a novel approach to counteracting the escalating issue of drug-resistant bacteria. ...